Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
8.05 MM warrants registered today. KW selling more of your investments.
https://www.sec.gov/Archives/edgar/data/1157075/000168316821005280/pharmacyte_s3.htm
May have been gleaned from this post of 6/24/2021 which contains response to the hold and steps initiated by PMCB to meet FDA requests.
The important thing is the THE HOLD HAS NOT BEEN LIFTED.
https://www.biospace.com/article/releases/pharmacyte-biotech-provides-update-on-status-of-activities-to-lift-clinical-hold/[url][/url][tag]insert-text-here[/tag]
The reason nothing happens quickly at PMCB is because there are no employees creating research, product or much else. They can barely get all of the financial reports done on time.
If you want a true biotech pharma doing breakthrough research, look somewhere else.
Even if this were to eventually get approved, what would be the price of the treatment? Based on the 10s of millions of dollars "spent on development", what would be the price be to recover all of the money spent on 10 years of development? How long would it take to recover your "investment", another 10 years or more?
You are correct. I saw the 52 week high posted at 55.50 so the 62 figure looked correct. It was .62 at its high. I remember it because I was on vacation at the time and have regretted not cashing out my 100K shares ever since.
This was just like my son's current infatuation with AMC. Been trying to get him to cash his original investment since February, but he refuses to sell. He's learning his lesson now.
To put the Kenny losses in perspective: the current share of stock at price of 8.26 was once worth 1500 * 62 = $93,000
What's worse is I see ETrade transactions for PMCBD now cost $6.95
Glad I got out before the IND, saved myself thousands of dollars.
Good luck to those that still remain.
" In addition, we are conducting joint research with major operating companies as a platform technology that can be applied to a wide range of cells and bacteria."
-----------------------
I noticed that the PMCB was addressed separately from this sentence about major operating companies. So PMCB is either a minor operating company, a minor non-operating company or a major non-operating company. Is this global warming or hell freezing over? Take your pick and good luck.
Besides The main company, can I assume that all of the subsidiaries are also remnants of failures? I don't see any income from them and searching for information on them returns little. They must be some sort of zombie companies.
"
And dont forget Crabtree helped to get Taxol to market while working at BM...and Hidalgo loves cell in box."
-------------
Taxol was approved in 1998. Tons of cancer research done since then. What has he done in the last 23 years?
PMCB market cap is currently listed on yahoo as 28.622 M, so KW is taking 3.5% of the company in salary each year? If I wasn't already out, I would be rushing to sell for the penny that is left.
--------- ----
“...there were 25% more deals worth over $1 billion up front. Many of them underscored the continued popularity of targeted oncology, immunology and rare-disease assets, as well as an increasing confidence in experimental therapy platform technologies using oligonucleotide, gene- or cell-therapy modalities.”
----------
Not sure why you included this. A billion would not help this POS. That's only .40 per share. Based on past history, if the shares pop to .41 (best case) you might get out with a long time investor might get out with a profit. However, that assumes there is a no more dilution and IND is approved; Neither will happen. I think the RS will hasten the BK. With fewer shares and higher price I think most volume will dry up.
Two institutions bought 80,642 shares? That's about $1,371 @ .017
That's not what I would call an investment; more like a spit in the wind.
Some traders probably had an extra few hundred dollars left over on a Friday afternoon and said what the heck it's only pocket money; What crapshoot can we put it on?
I happened to look at the Latest News in the section above the postings and here is the exact quote. Note the date. Seems like AN did everything required by PMCB; the Drug Master File was accepted by the FDA. It's the PMCB IND submission that is the problem. I guess whoever posts the news glossed over that news update...
Latest news...
The FDA’s Center for Biologics Evaluation and Research (CBER) successfully processed PharmaCyte’s DMF August 5th 2020
PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, announced today that the Drug Master File (DMF) that its partner, Austrianova, filed with the U.S. Food and Drug Administration (FDA) has been accepted without any questions or suggested changes.
The FDA’s Center for Biologics Evaluation and Research (CBER) successfully processed PharmaCyte’s DMF, which provides all confidential and detailed information covering the production of the CypCaps™ final product that was produced by Austrianova and will be used in PharmaCyte’s planned clinical trial in locally advanced, inoperable pancreatic cancer (LAPC).
PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner, said, "CBER’s acceptance and processing of our Drug Master File without any questions or comments is a credit to the painstaking work and dedication by Austrianova and our consultants to ensuring that the entire process is properly conducted and completed before any further documents are submitted to the FDA.
"We now look forward to presenting the FDA with our Investigational New Drug Application very soon for our planned clinical trial in locally advanced, inoperable pancreatic cancer."
A DMF is submitted to the FDA to provide detailed information about facilities, processes and materials used in the manufacturing, processing and packaging of human drugs. It is a prerequisite to securing approval and commercialization and ensures confidentiality of proprietary information related to the Active Pharmaceutical Ingredient (API). The information contained in a DMF is used to support, among other things, an IND.
The DMF requirements are complex and specific, encompassing every detail involved with the manufacture of the API – from raw materials to analytical methods, process development and optimization. The scrutiny goes all the way back to the starting materials used in the API.
It's just continuing its downhill roll...
Why would Viacyte want PMCB. Seems like Viacyte is years ahead of PMCB. They are actually doing R&D; They are already up to phase 2 in testing with clinical results in some cases. PMCB is only a model for stock scams; they have nothing of value after 20 years.
It may not qualify legally as a scam, but it certainly is a Pump N Dump.
Even the newbies on WSB can agree on this.
The rain will be from tears when this shuts down.
https://www.reddit.com/r/pennystocks/comments/lptysm/pmcb_46/
CasualGee DD
"After my research, I see a company that is in dire straights with only a faint glimmer of hope. There might be bits of good news here and there over the next year, but they are probably YEARS away from being able to demonstrate even a hope of producing something of any real value.
Honestly, I wouldn’t invest in this company. It’s got promise and it’s got some flashy product in development... but that just makes it an easy target to pump and dump. Beware."
Saw posting on Reddit WSB yesterday. The recent large jump caught the eyes of those crazy day traders. Watch your backs and prepare for possible whipsaw. Some pointed out it is a pump & dump so I would not anticipate any long term buyers.
---------------
Calling it a scam does not mean it's a scam...you still show no proof it's a scam...here look at proof that pmcb has partnerships and a company marketing cell in box...
https://www.uts.edu.au/research-and-teaching/research/explore/impact/engineering-cure-diabetes
https://www.unco.edu/news/newsroom/releases/unc-led-cannabis-research-sees-significant-progress.aspx
https://www.sigmaaldrich.com/technical-documents/articles/biology/cell-in-a-box.html
--------------------------
You prove my point with your articles. The second one has some merit.
The first deals with Melligen cells which are no longer considered a viable treatment.
The third is ancient. Just look at the footnotes; The most recent reference is from 2010 and others are even older. Ten years and no takers implies CIAB is not a viable choice.
Santa has left the building
From tech update during Ric Edelman podcast 9/19/2020:
Israel lab has come up with drug that reduces PC cancer cells in mice 90% after 14 daily injections.
https://www.edelmanfinancialengines.com/ric-edelman-radio/2020/09/sep-19-2020
tech update starts about 43:00 in.
I don't think there is a violation as the news is coming Monday. No disclosure of what the news is. A company selling its stock to fund operations; seems to be a logical assumption barring any other explanation.
Here's what one of the penny touters thinks of PMCB:
https://gov.capital/stock/pmcb-stock/
"As of 2020 July 23, Thursday current price of PMCB stock is 0.0161$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).
PharmaCyte Biotech stock price has been showing a declining tendency so we believe that similar market segments were not very popular in the given period.
Our site uses a custom algorithm based on Deep Learning that helps our users to decide if PMCB could be a good portfolio addition. These predictions take several variables into account such as volume changes, price changes, market cycles, similar stocks.
Future price of the stock is predicted at 0.0496$ (-100.000% ) after a year according to our prediction system.
This means that if you invested $100 now, your current investment may be worth 0$ on 2021 July 23, Friday. "
70M shares @ .005 = 350K. That should cover the cost of BK filing.
If you think getting an IND files is difficult, just think how long the CT will actually take. People are harder to manage than paperwork.
That was Qwest Diagnostics that got the nod, NOT PMCB
There will be doubt until the day it is filed, AND APPROVED.
If somebody came to you with a new way to employ a buggy whip would you encourage the inventor to take it to market or realize that horse propulsion is a product of the past?
I noticed near the end of the video he was asked what other companies/trials is he working with and PMCB was not mentioned.
Looks like the doctor has moved on to the currently fashionable bio-markers and newer drugs using them for targeting.
This could have been PMCB:
https://www.investors.com/news/technology/codx-stock-soars-coronavirus-test-proves-accurate/?src=A00220&yptr=yahoo
CODX was up 23% last I looked. Could have been PMCB, but then I realized 23% of .025 is only about a half-penny so big deal for PMCB? Don't think so.
And if you think 6 years is too long to get to phase 2 CT, how long will it take to do a phase 3, Marketing approval, etc. Another ten years before making any real money, assuming they cannot find someone gullible enough to buy all of PMCB.
10MM traded. Some trying to unload 598K shares at .0259
Another one ready to bite the dust
It's always darkest before everything goes completely black.
That future KABOOM someone is expecting will be KW's image exploding when they close the PMCB doors.
I came on when the name changed to Nuvilex. Talk back then was the same as now is it a scam or not? I did 5 months of DD before jumping in, thinking the odds were with PMCB. If successful, it would be great for my retirement funds. This was play money for me. I would never have invested my real retirement in this and I hope no one else has. I sold out at .036 and am glad I did. I look back here from time to time to review my decision and I see nothing has changed. How many years will it be before the diehards give up on this. I think Pink and friends plan to go down with the ship. I think the end will be before the end of the year as I cannot see how they can get any more funding from legitimate investors. Everything appears to be going towards salaries. I am willing to bet that even if Facet has the IND in prep mode, no one is currently working on it due to no payments being received from PMCB.
For the sake of cancer patients, I hope I am wrong, but I doubt it.
What does Sigma selling these test kits have to do with PMCB getting an IND files?????
These CIAB kits are development platforms, not actual drug products.
Is trading going on? My yahoo quote shows no bid or ask lots.
I think PMCB closed at an all-time low today.